• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,164
2,283
1,859
1,828
1,712

COUNTRY

877
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 271
  • 251
  • 65
  • 379
  • 673
  • 1,258
  • 1,621
  • 625
  • 883
  • 1,673
  • 2,638
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 727
  • 0
  • 97

PRICE

6,733
11,286
16,980
24,682

PUBLISHED

1,615
2,882
7,009
24,682

PRODUCT TYPE

20,309
3,174
856
164
74
44
21
21
12
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Asthma - Pipeline Review, H2 2013

Asthma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Asthma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Neuropathic Pain - Pipeline Review, H2 2013

Neuropathic Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neuropathic Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Bladder Cancer - Pipeline Review, H2 2013

Bladder Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Hepatitis C - Pipeline Review, H2 2013

Hepatitis C - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hepatitis C - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Myelodysplastic Syndrome - Pipeline Review, H2 2013

Myelodysplastic Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Myelodysplastic Syndrome - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Type 2 Diabetes - Pipeline Review, H2 2013

Type 2 Diabetes - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Type 2 Diabetes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Acute Pain - Pipeline Review, H2 2013

Acute Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acute Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM
ICT Spend Predictions in Medium-sized South African Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 ICT Spend Predictions in Medium-sized South African Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013 - Product Thumbnail Image

ICT Spend Predictions in Medium-sized South African Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

Synopsis This report illustrates how Kable expects Medium-sized South African Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software,...

August 2013
FROM

Lung Adenocarcinoma - Pipeline Review, H2 2013

Lung Adenocarcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Lung Adenocarcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Ebola Viral Infections - Pipeline Review, H2 2013

Ebola Viral Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ebola Viral Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Smoking Cessation - Pipeline Review, H2 2013

Smoking Cessation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Smoking Cessation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Genital Herpes - Pipeline Review, H2 2013

Genital Herpes - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Genital Herpes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Hypertension - Pipeline Review, H2 2013

Hypertension - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hypertension - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Major Depressive Disorder - Pipeline Review, H2 2013

Major Depressive Disorder - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Major Depressive Disorder - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Hemophilia - Pipeline Review, H2 2013

Hemophilia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hemophilia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM

Male Hypogonadism - Pipeline Review, H2 2013

Male Hypogonadism - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Male Hypogonadism - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Anaplastic Thyroid Cancer - Pipeline Review, H2 2013

Anaplastic Thyroid Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anaplastic Thyroid Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

August 2013
FROM

Fatty Liver Disease - Pipeline Review, H2 2013

Fatty Liver Disease - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Fatty Liver Disease - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

August 2013
FROM

Allergic Rhinitis - Pipeline Review, H2 2013

Allergic Rhinitis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Allergic Rhinitis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

August 2013
FROM

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2013

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2013', provides an overview of the indication’s...

August 2013
FROM
Loading Indicator

Our Clients

Our clients' logos